Protection still high six months after second dose
Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, six months after second doses, study finds. Protection against severe…
SARS-CoV-2 infection
Distinct immune response identified in the early phase of SARS CoV-2 infection
Distinct immune response identified in the early phase of SARS CoV-2 infection: Infection with the SARS-CoV-2 virus leads to a…
Cellular (T cell) immunity six months on
Cellular immunity to SARS-CoV-2 found at six months in non-hospitalised individuals: Cellular (T cell) immunity against SARS-CoV-2 is likely to…